HDFC Mutual Fund reduced its stake in Unichem Laboratories from 7.75% to 7.04%, selling 5,00,000 shares.
A pharmaceutical company engaged in the manufacture and distribution of generic medicines, active pharmaceutical ingredients, and contract manufacturing services across multiple therapeutic areas. Unichem Labs operates through an integrated manufacturing infrastructure, serving both domestic and international markets. The company distinguishes itself by offering affordable healthcare solutions while maintaining rigorous quality standards across its diverse product portfolio and manufacturing operations.
One of India's oldest and most trusted AMCs with over Rs 7.5 lakh crore in AUM. Founded in 1999 as a joint venture between HDFC Bank and Standard Life. MD and CEO Navneet Munot, formerly CIO of SBI MF, has reinforced the quality and compounding philosophy across equity schemes. HDFC Flexi Cap Fund and HDFC Mid-Cap Opportunities Fund are among the largest actively managed equity schemes in India.
